Oct. 13, 2025 — Medtronic plc recently announced it has received U.S. Food and Drug Administration (FDA) labeling ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
Oct. 7, 2025 — Cagent Vascular has announced the commercial launch of the Serranator PTA Serration Balloon Catheter in 7 ...
Oct. 7, 2025 — Medtronic has announced the full distribution of the Neuroguard IEP System (Neuroguard) after a ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
Oct. 7, 2025 — Nobles Medical Technology II, a provider of cardiovascular closure solutions, has announced that the U.S ...
Oct. 2, 2025 — AorticLab recently announced the U.S. Food and Drug Administration (FDA) has approved its Investigational ...
Sept. 30, 2025 — Cleerly has announced that coverage policies from UnitedHealthcare and Cigna for Cleerly LABS advanced ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
Sept. 29, 2025 — AngioSafe has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
Sept. 25, 2025 — Kardigan has introduced the three late-stage clinical programs leading its robust pipeline, each ...
Sept. 24, 2025 — The Family Heart Foundation, a leading research and advocacy organization, has announced the online ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
Sept. 22, 2025 — Nicklaus Children's Heart Institute in Miami, Florida, is now offering bedside transcatheter patent ...
Sept. 22, 2025 — The latest findings on heart failure (HF) published by the Heart Failure Society of America (HFSA) reve ...
Sept. 18, 2025 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for treating cardiovascular and ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
Sept. 9, 2025 — Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating ...
Sept. 9, 2025 — The John Ritter Foundation for Aortic Health, a nonprofit dedicated to raising awareness, advancing ...
Sept. 2, 2025 — Stereotaxis has announced the successful completion of the world’s first procedures using MAGiC Sweep, a ...
October 13, 2025